Karyopharm Therapeutics, Inc. (KPTI)
0.605
0.00 (0.00%)
USD |
NASDAQ |
Oct 09, 16:00
0.5959
-0.01
(-1.50%)
After-Hours: 20:00
Karyopharm Therapeutics Net Income (TTM) : -224.74M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -224.74M |
| March 31, 2026 | -194.97M |
| December 31, 2025 | -196.04M |
| September 30, 2025 | -124.62M |
| June 30, 2025 | -123.57M |
| March 31, 2025 | -62.52M |
| December 31, 2024 | -76.42M |
| September 30, 2024 | -87.48M |
| June 30, 2024 | -89.91M |
| March 31, 2024 | -146.34M |
| December 31, 2023 | -143.10M |
| September 30, 2023 | -139.77M |
| June 30, 2023 | -141.59M |
| March 31, 2023 | -158.02M |
| December 31, 2022 | -165.29M |
| September 30, 2022 | -88.06M |
| June 30, 2022 | -103.55M |
| March 31, 2022 | -108.07M |
| December 31, 2021 | -124.09M |
| September 30, 2021 | -206.23M |
| June 30, 2021 | -207.91M |
| March 31, 2021 | -200.76M |
| December 31, 2020 | -196.27M |
| September 30, 2020 | -201.50M |
| June 30, 2020 | -189.37M |
| Date | Value |
|---|---|
| March 31, 2020 | -186.36M |
| December 31, 2019 | -199.59M |
| September 30, 2019 | -209.15M |
| June 30, 2019 | -215.87M |
| March 31, 2019 | -206.11M |
| December 31, 2018 | -178.41M |
| September 30, 2018 | -159.24M |
| June 30, 2018 | -141.79M |
| March 31, 2018 | -137.53M |
| December 31, 2017 | -128.98M |
| September 30, 2017 | -116.88M |
| June 30, 2017 | -111.66M |
| March 31, 2017 | -112.44M |
| December 31, 2016 | -109.58M |
| September 30, 2016 | -111.69M |
| June 30, 2016 | -116.64M |
| March 31, 2016 | -119.17M |
| December 31, 2015 | -118.18M |
| September 30, 2015 | -115.06M |
| June 30, 2015 | -104.41M |
| March 31, 2015 | -88.15M |
| December 31, 2014 | -75.78M |
| September 30, 2014 | -62.00M |
| June 30, 2014 | -51.59M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Madrigal Pharmaceuticals, Inc. | -325.10M |
| Relay Therapeutics, Inc. | -286.04M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |